In this real-world Romanian cohort, reconstructive decision-making after age-stratified and technique-specific re-analysis, confirm that tumor biology (HER2, Ki-67, TNBC) did not independently influence IBR use. The gene discussed is ERBB2; the disease is neoplasm.